OrbiMed Advisors and an undisclosed investor also took part in the round, which Loxo said would be used to advance its lead product candidate through clinical proof of concept as well as launching a second programme.
Aisling’s Steven Elms and Dov Goldstein are present on the board of directors alongside OrbiMed private equity partner David Bonita.
Earlier today it emerged Aisling had taken part in a $27m equity financing round for laser cataract surgery business Lensar alongside Florida Growth and Florida Opportunity Funds.
PDL BioPharma provided $60m of debt financing for the business.
Lensar said it planned to use the investment to extend its global commercialisation and growth.
Copyright © 2013 AltAssets